Industry Event: JP Morgan Healthcare Conference 2021 – Biotech Showcase Webinar Topic: Clinical Studies in 2021: The Changing Dynamics and Challenges of Getting Studies Done Rapidly Featured Speaker: Andrew Schachter, Founder & CEO, Axiom Real-Time Metrics Topics covered: What are the key challenges and delays organizations are facing with study timelines? What are unique challenges faced by small-to-medium organizations with …
University of Oxford Selects Axiom Real-Time Metrics Fusion eClinical Suite for Its Unprecedented Global COPCOV Clinical Trial
TORONTO, July 07, 2020 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is pleased to announce its engagement with the University of Oxford for its large scale clinical trial focused on COVID-19 preventative treatments. The University of Oxford led trial will enroll 40,000 frontline healthcare workers and staff in the UK, Europe and …
Axiom to Sponsor PharmaVOICE Virtual Panel ‘The Critical Importance of ePRO (electronic Patient Reported Outcomes) in Clinical Research in Our Challenging and Evolving Times’
TORONTO, May 12, 2020 (GLOBE NEWSWIRE) — On May 14, 2020 Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services, will be participating in and sponsoring a PharmaVOICE virtual panel event. The event will bring together an esteemed panel of experts in clinical development/operations and data management. All panel members are currently deeply engaged in complex global …
Axiom Real-Time Metrics Mobilizes to Respond to Vital Clinical Trial Needs During COVID-19
TORONTO, March 30, 2020 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is responding to the unique and unprecedented circumstances the COVID-19 global pandemic. Andrew Schachter, Founder & CEO of Axiom, shared, “Being a global company, we are responding to our clients in this time of change and need for collaboration and innovation. …